mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.9 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.9 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |